An innovative graphene-based film helps shield people from disease-carrying mosquitos, according to a new study funded by the National
One element all mosquitoes have in common is their complex sense of smell. Mosquitoes must seek out blood meals (a mosquito “bite” to humans) to reproduce and water sources to lay eggs; however, they have poor vision and instead use scent to find their next meal.
The National Institute of Allergy and Infectious Diseases (NIAID)-funded researchers who developed a genetically modified mosquito-killing fungus, a weapon made from spider toxin, that destroys blood-sucking enemies from the inside and helps save people from disease and death.
Mosquitoes that landed on surfaces coated with the antimalarial compound atovaquone were completely blocked from developing Plasmodium falciparum (P. falciparum), the parasite that causes malaria, according to new research led by Harvard T.H. Chan School of Public Health.
One of the world’s oldest and deadliest diseases — remains a critically important public health and biomedical research challenge. Despite remarkable advances in reducing malaria incidence and deaths since 2000, recent progress has become stagnant and has even reversed in some regions.
The Government of Malawi has launched the world’s first malaria vaccine in a landmark pilot programme aimed at combating one of the world’s leading killers.
Malaria control campaign launched in Democratic Republic of the Congo to save lives and aid Ebola response
A spike in malaria cases is threatening the health of people in parts of the eastern Democratic Republic of the Congo (DRC) where health workers are also battling an Ebola outbreak.